Navigation Links
Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
Date:10/4/2007

than five years of age worldwide.

Important Safety Information about PREVNAR

In clinical trials (n=18,168), the most frequently reported adverse events included injection site reactions, fever (greater than or equal to 38 degrees C/100.4 degrees F), irritability, drowsiness, restless sleep, decreased appetite, vomiting, diarrhea, and rash. Risks are associated with all vaccines, including PREVNAR. Hypersensitivity to any vaccine component, including diphtheria toxoid, is a contraindication to its use. PREVNAR does not provide 100 percent protection against vaccine serotypes or protect against nonvaccine serotypes.

Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products, including with respect to our pipeline products; government cost-containment initiatives; restrictions on third-party payments for our p
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy
3. Wyeth Pharma Wins Law Suit
4. Verdict Against Wyeth Pharma in Prempro Case
5. FDA Approves Wyeths Oral Contraceptive Lybrel
6. Northfield Labs Receives FDA Comments
7. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
8. Trendsetters: Little girls fast track into ladies even before they know it
9. Periodontal disease can be predicted by trends in obesity!
10. Romantic and discreet trends in lingerie
11. Stringent budget for 2006/2007 portends unhealthy trends for HIV/AIDS patients.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... September 18, 2014 Specialty Teleradiology ... Westlake, OH, announces that they have achieved Meaningful ... a Complete Certified Ambulatory EHR-certified system developed by ... Teleradiology had a non MU compliant PACS and ... business grew from a niche in oncology to ...
(Date:9/17/2014)... 18, 2014 Recently, BambooIndustry.com, an outstanding company ... bamboo floorings . There are more than 1000 items ... launched a big promotion for these useful items. Each of ... % off. , “We are very proud to unveil ... say, all these items are made with natural materials by ...
(Date:9/17/2014)... IntimateRider, an inventor of classy sexual enhancement ... it has entered into a dealership agreement with new ... reason for the deal is the fact that All ... its sales potential, representatives at the mobility products firm ... latest products on the market both nationally and internationally." ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 US medical ... tons of medical waste in 2014. Due to public ... in landfills along with municipal solid waste. An increasing ... regulated medical waste (RMW). This includes disposable items that ... potentially infectious materials. As a result of increased regulation, ...
(Date:9/17/2014)... 2014 As kinship care continues to ... cannot live with their parents, emphasis on kinship care ... enhance services and supports for kinship caregivers and families. ... Kinship Care Conference is being held this week in ... practice, policy, program and service development for kinship caregivers, ...
Breaking Medicine News(10 mins):Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 2Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 3Health News:More Than 1000 Items Added To BambooIndustry.com’s Bamboo Flooring Collection 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2
... 7 Perot Systems,Corporation (NYSE: PER ) ... it acquired in August 2007, will fully transition ... toward full,integration. Perot Systems will now refer to ... its ability to access the global information,technology provider,s ...
... announced today that Immediate Past President and public,health leader ... home outside,East Lansing, Michigan. He was diagnosed with pancreatic ... served as the 162nd,president of the AMA from June ... on,preventive medicine and had been a longtime public health ...
... by a tumor or injury carry a severe psychological and ... in plastic surgery. Helmut Fischer and Wolfgang Gubisch present the ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... a woman who had had a tumor removed from the ...
... to bone marrow transplantation pioneered in part by a ... to be the only safe and effective cure for ... Lakshmanan Krishnamurti, MD, a pediatric hematologist/oncologist at Children,s Hospital, ... relies on reduced-intensity conditioning (RIC). RIC regimens are less ...
... Allscripts-Misys Healthcare,Solutions, Inc. (formerly named Allscripts Healthcare Solutions, ... ("Allscripts") and,headquartered in Chicago, Illinois announced today its ... Convertible Senior Debentures due 2024 (the,"Debentures") at a ... to 100% of the principal amount of the ...
... - Nearly 700 health plans evaluated based on ... 7 U.S. News Media Group and The,National ... fourth,annual edition of America,s Best Health Plans on ... millions of Americans prepare to,select their healthcare coverage, ...
Cached Medicine News:Health News:Perot Systems Announces Name Change of JJWild 2Health News:Perot Systems Announces Name Change of JJWild 3Health News:AMA Immediate Past President Ron Davis Loses Battle With Cancer, Leaves Enduring AMA and Public Health Legacy 2Health News:AMA Immediate Past President Ron Davis Loses Battle With Cancer, Leaves Enduring AMA and Public Health Legacy 3Health News:Children's Hospital study demonstrates how bone marrow transplant can cure sickle cell disease 2Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 2Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 3Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 4Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 2Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 3
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "Germany ... market data on the Germany Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... SANTA MONICA, Calif. , Sept. 17, 2014 /PRNewswire-USNewswire/ ... who is at the White House today for National ... Proposition 46 that consumer advocates released today. Consumer advocates ... woman who spoke out after losing her ... later discovering that the doctor had a history of ...
(Date:9/17/2014)... , Sept. 17, 2014  Decision ... colitis (CD/UC) patients eligible for biologic therapy, ... a biologic. Surveyed gastroenterologists cite patients, discomfort ... for low penetration rates, followed by cost-related ... UC patients receiving biologics, Janssen Biotech,s Remicade ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
... OncoSec Medical Incorporated (OTCBB:ONCS), which is developing ... to treat solid tumor cancers, today announced that ... and Lakeland Comprehensive Cancer Center in Lakeland, FL ... are screening patients for the Phase II metastatic ...
... International, Inc. (NASDAQ: BDSI ) announced that ... of further litigation in the patent infringement lawsuit previously ... that the case would be stayed pending resolution by ... proceedings and follows the recent rejection by the USPTO ...
Cached Medicine Technology:OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation 2Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation 3